vitiligo is a common pigmented skin disease characterized by the selective destruction of melanocytes, typically characterized by distinct milky white patches along the edges that can appear anywhere on the body. Vitiligo has a large impact on the appearance of patients, seriously affecting the life of patients, the global incidence of 0.5%-2%, the current incidence of China's population is about
Conditions
Interventions
Disease group:None
Control group:
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 99 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with vitiligo are of all genders and ages;There was no hormone therapy and no phototherapy in the first 3 months;There was no diabetes, autoimmune thyroiditis, pernicium anemia, psoriasis, atopic dermatitis or other inflammatory skin diseases;No abnormal cardiopulmonary function, no liver and kidney diseases, no abnormal coagulation function
Exclusion criteria
Exclusion criteria: Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VETF activity score;VASI score;Wood's lamp; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection of metal ion disturbance levels; | — |
Countries
China
Contacts
Public Contactlvhaozhen
Beijing Hospital
Outcome results
None listed